Analyze Diet
Histochemistry and cell biology2025; 163(1); 71; doi: 10.1007/s00418-025-02397-y

Distribution of endocannabinoid system receptors in the equine hoof: dysregulation as a potential therapeutic target for laminitis.

Abstract: A growing body of evidence indicates that the endocannabinoid system (ECS) is essential for controlling the homeostasis of the skin and that the ECS is modified in the presence of skin disease. It is plausible to expect that the lamellar junction of the hoof expresses cannabinoid receptors and that their expression could be affected by lamellar disease. The goal of this study was to characterise the cannabinoid receptor type 1 (CB1R) and type 2 (CB2R) and the G protein-coupled receptor 55 (GPR55) within the dermo-epidermal junction of the hooves of healthy and laminitic horses. The expression of the CB1R, CB2R, and GPR55 within the dermo-epidermal lamellar junction of six healthy and 12 laminitic hooves was studied using polymerase chain reaction (PCR) and immunofluorescence. Both the mRNA and protein expression of the CB1R, CB2R, and GPR55 were found in the dermo-epidermal lamellar junction of horse hooves. The immunolabelling was expressed by the epithelial cells of the primary and secondary laminae of healthy hooves (CB2R > GPR55 > CB1R). The presence of CB1R, CB2R, and GPR55 immunoreactivity in the healthy laminar epithelial cells, coupled with increased protein expression in pathological epithelial cells, provided strong motivation for future investigation. These findings suggest that cannabinoid compounds which interact with these receptors may influence lamellar healing and mitigate inflammation in hoof diseases, particularly laminitis.
Publication Date: 2025-07-01 PubMed ID: 40593311PubMed Central: 7023045DOI: 10.1007/s00418-025-02397-yGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study analyzes the presence and potential role of endocannabinoid system (ECS) receptors in the hoof health of horses, particularly in connection with a disease called laminitis. It suggests that targeting these receptors could provide therapeutic relief for horses suffering from the disease.

Research Objectives and Methods

  • This research aimed at examining cannabinoids, specifically cannabinoid receptor type 1 (CB1R), type 2 (CB2R), and G protein-coupled receptor 55 (GPR55) in the dermo-epidermal junction, the interface between the outermost layer of the skin and the underlying tissue, of the hooves of healthy and laminitic horses.
  • Using polymerase chain reaction (PCR) and immunofluorescence, technologies that allow scientists to replicate and visualize specific DNA sequences, the researchers studied the expression of these cannabinoid receptors in six healthy horse hooves and 12 laminitic ones.

Findings

  • Both the mRNA and protein expression of the CB1R, CB2R and GPR55 were found at the dermo-epidermal lamellar junction of the horse hooves. Immunolabelling, a technique that uses antibodies to detect specific antigens, showed the presence of these receptors in the epithelial cells (the cells that cover the outside of the body and line organs and cavities within the body) of the primary and secondary laminae of healthy hooves.
  • There was more of the CB2R receptor than GPR55 or CB1R in the healthy hooves. Interestingly, there was an increased expression of these receptors in pathological or disease-affected cells.

Implications and Future Scope

  • The findings of this research suggest that the endocannabinoid system could play a significant role in hoof health and disease. The detection of CB1R, CB2R, and GPR55 immunoreactivity – how reactive the system is to these receptors – in the healthy laminar epithelial cells and increased expression in pathological cells hints at this potential.
  • These increases provide a compelling reason to continue exploring how cannabis-derived compounds that interact with these receptors could influence the healing of lamellar tissues and reduce inflammation in hoof diseases, particularly laminitis.

Cite This Article

APA
Zamith Cunha R, Gobbo F, Morini M, Zannoni A, Mainardi C, D'arpe L, Gramenzi A, Chiocchetti R. (2025). Distribution of endocannabinoid system receptors in the equine hoof: dysregulation as a potential therapeutic target for laminitis. Histochem Cell Biol, 163(1), 71. https://doi.org/10.1007/s00418-025-02397-y

Publication

ISSN: 1432-119X
NlmUniqueID: 9506663
Country: Germany
Language: English
Volume: 163
Issue: 1
Pages: 71

Researcher Affiliations

Zamith Cunha, Rodrigo
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy. rodrigo.zamithcunha@studio.unibo.it.
  • Department of Veterinary Medicine, University of Teramo, Teramo, Italy. rodrigo.zamithcunha@studio.unibo.it.
Gobbo, Francesca
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Morini, Maria
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Zannoni, Augusta
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Mainardi, Carlo
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
D'arpe, Lorenzo
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.
Gramenzi, Alessandro
  • Department of Veterinary Medicine, University of Teramo, Teramo, Italy.
Chiocchetti, Roberto
  • Department of Veterinary Medical Sciences (UNI EN ISO 9001:2008), University of Bologna, Bologna, Italy.

MeSH Terms

  • Animals
  • Horses
  • Hoof and Claw / metabolism
  • Hoof and Claw / pathology
  • Receptors, Cannabinoid / metabolism
  • Receptors, Cannabinoid / genetics
  • Receptors, Cannabinoid / analysis
  • Inflammation / metabolism
  • Inflammation / drug therapy
  • Horse Diseases / metabolism
  • Horse Diseases / drug therapy
  • Horse Diseases / pathology
  • Endocannabinoids / metabolism
  • Foot Diseases / metabolism
  • Foot Diseases / veterinary
  • Receptor, Cannabinoid, CB2 / metabolism
  • Receptor, Cannabinoid, CB2 / genetics
  • Receptor, Cannabinoid, CB1 / metabolism
  • Receptor, Cannabinoid, CB1 / genetics

Conflict of Interest Statement

Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. Ethics approval and consent to participate: According to Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 regarding the protection of animals used for scientific purposes, Italian legislation (D. Lgs. n. 26/2014) did not require any approval by competent authorities or ethics committees as this study did not influence any therapeutic decisions. Consent for publication: All the authors have approved the publication of this manuscript.

References

This article includes 58 references
  1. Andradas C, C MM, P-G E, G M, S C. The role of GPR55 in cancer. 2013;pp 115–133.
  2. Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants 2019;9:21.
    doi: 10.3390/antiox9010021pubmed: 31881765pmc: 7023045google scholar: lookup
  3. Baskerville CL, Chockalingham S, Harris PA, Bailey SR. The effect of insulin on equine lamellar basal epithelial cells mediated by the insulin-like growth factor-1 receptor. PeerJ 2018;6:e5945.
    doi: 10.7717/peerj.5945pubmed: 30519508pmc: 6275117google scholar: lookup
  4. Belknap JK, Giguere S, Pettigrew A. Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet J 2007;39:42–47.
    doi: 10.2746/042516407X155406pubmed: 17228594google scholar: lookup
  5. Blázquez C, Carracedo A, Barrado L. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 2006;20:2633–2635.
    doi: 10.1096/fj.06-6638fjepubmed: 17065222google scholar: lookup
  6. Burns TA, Watts MR, Weber PS. Distribution of insulin receptor and insulin-like growth factor-1 receptor in the digital laminae of mixed-breed ponies: an immunohistochemical study. Equine Vet J 2013;45:326–332.
  7. Cassimeris L, Armstrong C, Burger QC. Continuous digital hypothermia reduces expression of keratin 17 and 1L–17A inflammatory pathway mediators in equine laminitis induced by hyperinsulinemia. Vet Immunol Immunopathol 2021;241:110326.
    doi: 10.1016/j.vetimm.2021.110326pubmed: 34562796google scholar: lookup
  8. Cheng Z, Teo G, Krueger S. Differential dynamics of the mammalian mRNA and protein expression response to misfolding stress. Mol Syst Biol .
    doi: 10.15252/msb.20156423pubmed: 26792871pmc: 4731011google scholar: lookup
  9. Chiocchetti R, Galiazzo G, Tagliavia C. Cellular distribution of canonical and putative cannabinoid receptors in canine cervical dorsal root ganglia. Front Vet Sci 2019;6:313.
    doi: 10.3389/fvets.2019.00313pubmed: 31608295pmc: 6761858google scholar: lookup
  10. Chiocchetti R, Rinnovati R, Tagliavia C. Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia. Equine Vet J 2021;53:549–557.
    doi: 10.1111/evj.13305pubmed: 32524649google scholar: lookup
  11. Chiocchetti R, De Silva M, Aspidi F. Distribution of cannabinoid receptors in keratinocytes of healthy dogs and dogs with atopic dermatitis. Front Vet Sci .
    doi: 10.3389/fvets.2022.915896pubmed: 36187821pmc: 9521433google scholar: lookup
  12. Czifra G, Szöllősi AG, Tóth BI. Endocannabinoids regulate growth and survival of human eccrine sweat gland-derived epithelial cells. J Investig Dermatol 2012;132:1967–1976.
    doi: 10.1038/jid.2012.118pubmed: 22513781google scholar: lookup
  13. Douglas JE, Thomason JJ. Shape, orientation and spacing of the primary epidermal laminae in the hooves of neonatal and adult horses (Equus caballus). Cells Tissues Organs 2000;166:304–318.
    doi: 10.1159/000016744pubmed: 10765026google scholar: lookup
  14. Elliott J, Bailey SR. A review of cellular and molecular mechanisms in endocrinopathic, sepsis-related and supporting limb equine laminitis. Equine Vet J 2023;55:350–375.
    doi: 10.1111/evj.13933pubmed: 36847165google scholar: lookup
  15. Ellis KL, Contino EK. Treatment using cannabidiol in a horse with mechanical allodynia. Equine Vet Educ .
    doi: 10.1111/eve.13168google scholar: lookup
  16. Fails AD. Functional anatomy of the equine musculoskeletal system. 2020;pp 1–65.
  17. Gabrielsson L, Mattsson S, Fowler CJ. Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy. Br J Clin Pharmacol 2016;82:932–942.
    doi: 10.1111/bcp.13020pubmed: 27220803pmc: 5094513google scholar: lookup
  18. Galiazzo G, Giancola F, Stanzani A. Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract. Histochem Cell Biol 2018;150:187–205.
    doi: 10.1007/s00418-018-1684-7pubmed: 29882158google scholar: lookup
  19. Galiazzo G, Tagliavia C, Giancola F. Localisation of cannabinoid and cannabinoid-related receptors in the horse ileum. J Equine Vet Sci 2021;104:103688.
    doi: 10.1016/j.jevs.2021.103688pubmed: 34416995google scholar: lookup
  20. Galiazzo G, De Silva M, Giancola F. Cellular distribution of cannabinoid-related receptors TRPV1, PPAR-gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia. Equine Vet J 2022;54:788–798.
    doi: 10.1111/evj.13499google scholar: lookup
  21. Hargrove JL, Schmidt FH. The role of mRNA and protein stability in gene expression. FASEB J 1989;3:2360–2370.
    doi: 10.1096/fasebj.3.12.2676679pubmed: 2676679google scholar: lookup
  22. Harvey BS, Nicotra LL, Vu M, Smid SD. Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. Cytokine 2013;63:209–217.
    doi: 10.1016/j.cyto.2013.04.032pubmed: 23706402google scholar: lookup
  23. Henstridge CM, Balenga NAB, Kargl J. Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55. Mol Endocrinol 2011;25:1835–1848.
    doi: 10.1210/me.2011-1197pubmed: 21964594pmc: 5417173google scholar: lookup
  24. Hill JD, Zuluaga-Ramirez V, Gajghate S. Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol 2018;175:3407–3421.
    doi: 10.1111/bph.14387pubmed: 29888782pmc: 6057896google scholar: lookup
  25. Iannotti FA, Di Marzo V, Petrosino S. Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders. Prog Lipid Res 2016;62:107–128.
    doi: 10.1016/j.plipres.2016.02.002pubmed: 26965148google scholar: lookup
  26. Kawasako K, Higashi T, Nakaji Y. Histologic evaluation of the diversity of epidermal laminae in hooves of horses without clinical signs of laminitis. Am J Vet Res 2009;70:186–193.
    doi: 10.2460/ajvr.70.2.186pubmed: 19231949google scholar: lookup
  27. Kozubek M, Matula P. An efficient algorithm for measurement and correction of chromatic aberrations in fluorescence microscopy. J Microsc 2000;200:206–217.
  28. Kupczyk P, Reich A, Szepietowski JC. Cannabinoid system in the skin—a possible target for future therapies in dermatology. Exp Dermatol 2009;18:669–679.
  29. Kupczyk P, Rykala M, Serek P. The cannabinoid receptors system in horses: tissue distribution and cellular identification in skin. J Vet Intern Med 2022;36:1508–1524.
    doi: 10.1111/jvim.16467pubmed: 35801813pmc: 9308437google scholar: lookup
  30. Leise B. The role of neutrophils in equine laminitis. Cell Tissue Res 2018;371:541–550.
    doi: 10.1007/s00441-018-2788-zpubmed: 29397426google scholar: lookup
  31. Ligresti A, De Petrocellis L, Di Marzo V. From phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacology. Physiol Rev 2016;96:1593–1659.
    doi: 10.1152/physrev.00002.2016pubmed: 27630175google scholar: lookup
  32. Liu B, Song S, Jones PM, Persaud SJ. GPR55: from orphan to metabolic regulator?. Pharmacol Ther 2015;145:35–42.
  33. Liu Y, Beyer A, Aebersold R. On the dependency of cellular protein levels on mRNA abundance. Cell 2016;165:535–550.
    doi: 10.1016/j.cell.2016.03.014pubmed: 27104977google scholar: lookup
  34. Liu C, Li H, Xu F. Cannabidiol protects human skin keratinocytes from hydrogen-peroxide-induced oxidative stress via modulation of the caspase-1–IL-1β axis. J Nat Prod 2021;84:1563–1572.
    doi: 10.1021/acs.jnatprod.1c00083pubmed: 33955754google scholar: lookup
  35. Montecucco F, Di Marzo V. At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction. Trends Pharmacol Sci 2012;33:331–340.
    doi: 10.1016/j.tips.2012.03.002pubmed: 22503477google scholar: lookup
  36. Morales P, Hurst DP, Reggio PH. Molecular targets of the phytocannabinoids: a complex picture. Prog Chem Org Nat Prod 2017;103:103–131.
  37. Petrosino S, Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br J Pharmacol 2017;174:1349–1365.
    doi: 10.1111/bph.13580pubmed: 27539936google scholar: lookup
  38. Piñeiro R, Maffucci T, Falasca M. The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation. Oncogene 2011;30:142–152.
    doi: 10.1038/onc.2010.417pubmed: 20838378google scholar: lookup
  39. Polidoro G, Galiazzo G, Giancola F. Expression of cannabinoid and cannabinoid-related receptors in the oral mucosa of healthy cats and cats with chronic gingivostomatitis. J Feline Med Surg 2021;23:679–691.
    doi: 10.1177/1098612X20970510pubmed: 33174485google scholar: lookup
  40. Pollitt CC. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet J 1996;28:38–46.
  41. Pollitt CC. The anatomy and physiology of the suspensory apparatus of the distal phalanx. Vet Clin N Am Equine Pract 2010;26:29–49.
  42. Pryimak N, Zaiachuk M, Kovalchuk O, Kovalchuk I. The potential use of cannabis in tissue fibrosis. Front Cell Dev Biol .
    doi: 10.3389/fcell.2021.715380pubmed: 34708034pmc: 8542845google scholar: lookup
  43. Romero-Zerbo SY, Rafacho A, Díaz-Arteaga A. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. J Endocrinol 2011;211:177–185.
    doi: 10.1530/JOE-11-0166pubmed: 21885477google scholar: lookup
  44. Scheau C, Badarau IA, Mihai L-G. Cannabinoids in the pathophysiology of skin inflammation. Molecules 2020;25:652.
    doi: 10.3390/molecules25030652pubmed: 32033005pmc: 7037408google scholar: lookup
  45. Silver RJ. The endocannabinoid system of animals. Animals 2019;9:686.
    doi: 10.3390/ani9090686pubmed: 31527410pmc: 6770351google scholar: lookup
  46. Simcocks AC, O’Keefe L, Jenkin KA. A potential role for GPR55 in the regulation of energy homeostasis. Drug Discov Today 2014;19:1145–1151.
    doi: 10.1016/j.drudis.2013.12.005pubmed: 24370891google scholar: lookup
  47. Sugawara K, Zákány N, Tiede S. Human epithelial stem cell survival within their niche requires “tonic” cannabinoid receptor 1-signalling—lessons from the hair follicle. Exp Dermatol 2021;30:479–493.
    doi: 10.1111/exd.14294pubmed: 33523535google scholar: lookup
  48. Tam J, Liu J, Mukhopadhyay B. Endocannabinoids in liver disease. Hepatology 2011;53:346–355.
    doi: 10.1002/hep.24077pubmed: 21254182google scholar: lookup
  49. Tudurí E, López M, Diéguez C. GPR55 and the regulation of glucose homeostasis. Int J Biochem Cell Biol 2017;88:204–207.
    doi: 10.1016/j.biocel.2017.04.010pubmed: 28457969google scholar: lookup
  50. Van Eps AW, Pollitt CC. Equine laminitis: cryotherapy reduces the severity of the acute lesion. Equine Vet J 2004;36:255–260.
    doi: 10.2746/0425164044877107pubmed: 15147134google scholar: lookup
  51. Wang L-L, Zhao R, Li J-Y. Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing. Eur J Pharmacol 2016;786:128–136.
    doi: 10.1016/j.ejphar.2016.06.006pubmed: 27268717google scholar: lookup
  52. Wilkinson JD, Williamson EM. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci 2007;45:87–92.
  53. Williams MR, Holbrook TC, Maxwell L. Pharmacokinetic evaluation of a cannabidiol supplement in horses. J Equine Vet Sci 2022;110:103842.
    doi: 10.1016/j.jevs.2021.103842pubmed: 34923070google scholar: lookup
  54. Yocom AF, O’Fallon ES, Gustafson DL, Contino EK. Pharmacokinetics, safety, and synovial fluid concentrations of single- and multiple-dose oral administration of 1 and 3 mg/kg cannabidiol in horses. J Equine Vet Sci 2022;113:103933.
    doi: 10.1016/j.jevs.2022.103933pubmed: 35307550google scholar: lookup
  55. Zamith Cunha R, Semprini A, Salamanca G. Expression of cannabinoid receptors in the trigeminal ganglion of the horse. Int J Mol Sci 2023;24:15949.
    doi: 10.3390/ijms242115949pubmed: 37958932pmc: 10648827google scholar: lookup
  56. Zamith Cunha R, Semprini A, Salamanca G. Expression of cannabinoid receptors in the trigeminal ganglion of the horse. Int J Mol Sci .
    doi: 10.3390/ijms242115949pubmed: 37958932pmc: 10648827google scholar: lookup
  57. Zamith Cunha R, Zannoni A, Salamanca G. Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint. Front Vet Sci .
    doi: 10.3389/fvets.2023.1045030pubmed: 36937015pmc: 10020506google scholar: lookup
  58. Zannoni A, Bombardi C, Dondi F. Proteinase-activated receptor 2 expression in the intestinal tract of the horse. Res Vet Sci 2014;96:464–471.
    doi: 10.1016/j.rvsc.2014.03.006pubmed: 24656343google scholar: lookup

Citations

This article has been cited 0 times.